123Tom's TA study group

[Citrati]

IMO, more important than financials, except for guidance as to funds needed for the next 12-18 months, is what guidance they give on trial time lines, enrollment expectations, interfacing with FDA etc.
If it is only about the financials then a 15%+ drop becomes greater than 50/50 odds. NDA's if any would be a positive as well. Any news about funding from Australian Gov or health system.

Be interested what the other AVXL'ers that frequent here think.